Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Combined Trial for Two DePuy Hip Lawsuits to Move Forward in N.J. August 19, 2013 Austin Kirk Add Your Comments A “bellwether” trial scheduled to begin early next year in New Jersey state court will involve a combined trial of two DePuy hip replacement lawsuits, after the judge presiding over the litigation denied a request by Johnson & Johnson to split the cases and schedule them for separate trial dates. There are currently more than 10,000 product liability lawsuits filed in state and federal courts throughout the United States involving recalled DePuy ASR hip implants. At least 650 of those cases are pending in New Jersey state court, where they are consolidated before Judge Brian R. Martinotti in Bergen County as part of an MCL or Multi-County Litigation. Learn More About Hip Replacement Lawsuits If you or a loved one experienced complications or needed revision surgery due to a defective hip implant, you may be entitled to financial compensation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Hip Replacement Lawsuits If you or a loved one experienced complications or needed revision surgery due to a defective hip implant, you may be entitled to financial compensation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As part of the coordinated proceedings in New Jersey state court, a small group of cases have been prepared for early trial dates, known as “bellwether” cases because they are designed to help the parties gauge how juries may respond to certain evidence and testimony that will likely be similar to what is offered in other cases. In April 2013, Judge Martinotti scheduled the first bellwether trial in New Jersey to begin on January 13, 2014, involving a combined trial for similar product liability lawsuits filed by Barbara Gullo and Kevin Coughlin and his wife, Kathleen. In response to a motion filed by Johnson & Johnson and their DePuy Orthopaedics subsidiary asking that the cases be split into separate bellwether trials, Judge Martinotti issued an Order (PDF) on August 13, indicating that the cases will proceed as part of a combined trial that will go before the same jury. Trial Set to Begin January 2014 in New Jersey The DePuy ASR is a metal-on-metal hip replacement system that was recalled in August 2010 amid reports that users were experiencing problems within a few years after it was implanted. The Gullo and Couglin cases raise similar allegations to those brought in all of the other complaints, claiming that DePuy Orthopaedics designed and sold a defective and dangerous medical device, which increased the risk of loosening and failure by releasing microscopic metallic debris as the metal parts rub against each other during normal use. Attorneys for DePuy and Johnson & Johnson argued that combining the cases as part of one trial would not be fair and could prejudice and confuse the jury. They also argued that the consolidated case would lead to a longer trial. However, Judge Martinotti disagreed. Although there are some factual differences between Gullo and Coughlin cases, Judge Martinotti indicated that there are a sufficient number of similar legal and factual issues to justify consolidation. In addition to New Jersey’s strong public policy in support of consolidation and judicial efficiency, Judge Martinotti pointed out that both Plaintiffs’ cases are governed by New York law, each underwent DePuy ASR hip replacement surgery due to degenerative joint disease, each required revision due to pain and elevated metal ion levels, the instructions for use of the implant were the same at the time of each of their surgeries and the plaintiffs’ surgeons interacted with the same sales distributor. Thousands of DePuy ASR Lawsuits Filed In addition to the New Jersey state court litigation, DePuy ASR lawsuits are pending elsewhere throughout the United States and at least two cases have already been presented to state court juries. In March, a California jury awarded $8.3 million in damages in the first DePuy ASR trial in the country, after the plaintiff was given an expedited trial date due to his grave health. However, a subsequent trial in Illinois state court ended in a defense verdict in April, after the jury concluded that the manufacturer was not liable for failing to warn about the risk of problems. In the federal court system, all lawsuits over DePuy ASR implants filed in U.S. District Courts throughout the country have been centralized for coordinated pretrial proceedings in the Northern District of Ohio, as part of an MDL or Multi-District Litigation. In the DePuy ASR MDL, a small group of cases are also being prepared for early trial dates, with the first case scheduled to begin on September 9, involving a lawsuit filed by Ann McCracken, who alleges that she received one of the metal-on-metal implants months before it was recalled from the market and required revision surgery less than two years later. The outcomes of these early trial dates may help the parties reach potential settlement agreements in a large number of cases. Otherwise, Johnson & Johnson and DePuy could face hundreds of individual trial dates in courts throughout the United States over the coming years. DePuy Hip Recall and Metal-on-Metal Hip Problems The DePuy ASR hip features a controversial metal-on-metal design, with a metal ball that rotates within a metal acetabular cup. Plaintiffs allege that this results in the release of metal particles, which may cause infection and loosening of the components, often resulting in the need for risky revision surgery. A DePuy ASR recall was issued in August 2010, after the manufacturer acknowledged that post-marketing data suggested a higher-than-expected failure rate. While initial reports released by the company found a failure rate of 12% to 13%, some outside experts estimated the failure rate at a about 30% over six years. Similar problems have also been seen with other metal-on-metal hip implants, and a number of product liability lawsuits have also been filed over these similar products, including the Biomet M2A Magnum, the Wright Medical Conserve Cup, and the DePuy Pinnacle hip. Tags: DePuy, Depuy ASR Hip, Johnson & Johnson, Metal-on-Metal Hip Replacement, Metallosis, New Jersey More DePuy ASR Hip Lawsuit Stories Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant December 26, 2024 Zimmer Biomet Lawsuit Filed Over RibFix Blu Implant Fracture September 25, 2024 Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)